U.S. Defibrillator Market Size & Outlook, 2024-2030
The defibrillator market in the United States is expected to reach a projected revenue of US$ 4,320.1 million by 2030. A compound annual growth rate of 7.3% is expected of the United States defibrillator market from 2024 to 2030.
In terms of revenue, U.S. accounted for 36.0% of the defibrillator market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. defibrillator market is projected to lead the regional market in terms of revenue in 2030.
Canada is the fastest growing regional market in North America and is projected to reach USD 768.6 million by 2030.
With the rise in the prevalence of sudden cardiac arrests in the U.S. and the high mortality associated with these diseases, the demand for defibrillators is expected to rise. According to the Heart and Stroke Statistics 2022 by American Heart Association, over 356,000 out-of-hospital cardiac arrests are reported in the U.S. annually, and around 90% of them are fatal.
One of the major drivers in the U.S. for defibrillators is the availability of reimbursement policies. Defibrillators are also eligible for Flexible Spending Account (FSA), Health Saving Account (HSA), and Health Reimbursement Arrangement (HRA).
An FSA enables the employee to invest a part of his salary for medical expenses, and money deducted from this account is tax-free. In addition, FSAs are not eligible for payroll taxes. HSA is a savings account for medical expenses, accessible to citizens of the U.S. who have enrolled in the High-Deductible Health Plan (HDHP).
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Defibrillator Market Outlook will help companies and investors design strategic landscapes.
Implantable Cardioverter Defibrillator (Icd) was the largest segment with a revenue share of 51.65% in 2023.
Horizon Databook has segmented the U.S. defibrillator market based on implantable cardioverter defibrillator (icd), external defibrillator covering the revenue growth of each sub-segment from 2018 to 2030.
With the rise in the prevalence of sudden cardiac arrests in the U.S. and the high mortality associated with these diseases, the demand for defibrillators is expected to rise. According to the Heart and Stroke Statistics 2022 by American Heart Association, over 356,000 out-of-hospital cardiac arrests are reported in the U.S. annually, and around 90% of them are fatal.
One of the major drivers in the U.S. for defibrillators is the availability of reimbursement policies. Defibrillators are also eligible for Flexible Spending Account (FSA), Health Saving Account (HSA), and Health Reimbursement Arrangement (HRA).
An FSA enables the employee to invest a part of his salary for medical expenses, and money deducted from this account is tax-free. In addition, FSAs are not eligible for payroll taxes. HSA is a savings account for medical expenses, accessible to citizens of the U.S. who have enrolled in the High-Deductible Health Plan (HDHP).
U.S. Defibrillator Market Product Outlook (Revenue, USD Million , 2018-2030)
Implantable Cardioverter Defibrillator (ICD)
External Defibrillator
U.S. Defibrillator Market end Use Outlook (Revenue, USD Million , 2018-2030)
Hospital
Pre hospital
Public Access market
Alternate care market
Home healthcare
Reasons to subscribe to Defibrillator Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Defibrillator Market Outlook databook
Our clientele includes a mix of Defibrillator Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Defibrillator Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Defibrillator Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.